Showing results (401-410 of 635) with videos related to
Sort By:
Pageof 64
JACC. Heart Failure|July 16, 2018
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT TrialMaja Cikes, Brian Claggett, Amil M Shah, et al.JACC. Heart Failure|June 6, 2024
Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to 2Safia Chatur, Iris E Beldhuis, Brian L Claggett, et al.European Journal of Heart Failure|March 2, 2026
Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trialMisato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.JACC. Heart Failure|April 16, 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart FailureKevin Damman, Mauro Gori, Brian Claggett, et al.Journal of the American College of Cardiology|March 20, 2024
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart FailureDavid A Morrow, Eric J Velazquez, Akshay S Desai, et al.JAMA Cardiology|November 11, 2023
Natural Language Processing for Adjudication of Heart Failure in a Multicenter Clinical Trial: A Secondary Analysis of a Randomized Clinical TrialJonathan W Cunningham, Pulkit Singh, Christopher Reeder, et al.Lancet (London, England)|August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trialsMuthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.European Heart Journal|November 8, 2024
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trialsSimon Wandel, Akshay S Desai, Chien-Wei Chen, et al.JAMA Cardiology|October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVERAkshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.Journal of Cardiac Failure|May 27, 2024
Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF TrialMarat Fudim, Derek D Cyr, Jonathan H Ward, et al.Pageof 64